Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04949191 |
| Consolidated Lead Sponsor | Incyte |
| Therapeutic Condition Cohort | Rare Genetic, Women's Health, and Other |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 10 participants (ACTUAL) |
| Registered Start Date | 2021-07-08 |
| WhyStopped Classification | Strategic / Business / Sponsor Decision |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| MD Anderson Cancer Center | Houston, TX | Open Hospital Dossier -> |
| Fondazione IRCCS Istituto Nazionale dei Tumori | Milan, Italy | Open Hospital Dossier -> |
| Kanagawa Cancer Center | Yokohama, Japan | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Incyte across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.